You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ZYME Exercise Disclosure
Schayowitz Adam · SEC Form 4 · Filed Oct 9, 2026
Exercise
Calculated transaction value
$0
Schayowitz Adam EVP, Head Of R&d
ZYME
Zymeworks Inc
ZYME
Transaction date
Oct 9, 2026
Public filing date
Oct 9, 2026
Filing lag
Filed same day
ZYME daily price context
Close on/before transaction
$25.79
Oct 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Common Stock
- Quantity / price
- 37,037 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002127119-26-000006
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$357.56K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Zymeworks Inc. ZYME Current | Exercise | Oct 9, 2026 | $0 |
| Zymeworks Inc. ZYME | Sale | Oct 9, 2026 | $357.56K |
| Zymeworks Inc. ZYME | Exercise | Oct 9, 2026 | $0 |